Weathering The ‘Cytokine Storm’: US FDA Gives EUA To Blood Purification Machine
Executive Summary
US regulators have given emergency use authorization to a blood purification system that can remove excess cytokines to help patients recover from the novel coronavirus. Recent studies on COVID-19 indicate some patients may be dying from the body producing excess amounts of the proteins that direct the immune system’s response.
You may also be interested in...
It’s Raining EUAs: US FDA Drops Slew Of EUAs In Response To COVID-19
While US regulators have ramped up the number of authorizations they’ve granted to companies on an emergency basis in response to the COVID-19 crisis, they really kicked things into high gear in just the past few days. On 10 April the agency issued a record number of EUAs in response to the pandemic.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.